Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The cysteine-rich PDZ-binding protein pseudogene (ENSG00000257323) is a noncoding DNA sequence that resembles the gene encoding cysteine-rich PDZ-binding protein (CRIPT), but it has accumulated mutations that render it nonfunctional at the protein level[5][7][9]. Like most pseudogenes, it does not produce a functional protein and thus is not a receptor, enzyme, transporter, or other druggable target[5][7]. Some pseudogenes can act at the RNA level to modulate expression of other genes through miRNA interactions, but the functions of most pseudogenes remain unknown and are not therapeutically actionable[1][2][4]. Pseudogenes are of interest in evolutionary genomics but rarely have direct biological or clinical relevance. ENSG00000257323 is NOT a therapeutic target but a pseudogene—"gene-like" DNA disabled from producing a protein[5][7]. Any designation as a receptor, transporter, or drug target is incorrect.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cysteine-rich PDZ-binding protein pseudogene.